HIV Integrase Inhibitors Block Replication of Alpha-, Beta-, and Gammaherpesviruses

DSpace/Manakin Repository

HIV Integrase Inhibitors Block Replication of Alpha-, Beta-, and Gammaherpesviruses

Citable link to this page


Title: HIV Integrase Inhibitors Block Replication of Alpha-, Beta-, and Gammaherpesviruses
Author: Yan, Zhipeng; Bryant, Kevin F.; Gregory, Sean M.; Angelova, Magdalena; Dreyfus, David H.; Zhao, Xue Zhi; Coen, Donald M.; Burke, Terrence R.; Knipe, David M.

Note: Order does not necessarily reflect citation order of authors.

Citation: Yan, Zhipeng, Kevin F. Bryant, Sean M. Gregory, Magdalena Angelova, David H. Dreyfus, Xue Zhi Zhao, Donald M. Coen, Terrence R. Burke, and David M. Knipe. 2014. “HIV Integrase Inhibitors Block Replication of Alpha-, Beta-, and Gammaherpesviruses.” mBio 5 (4): e01318-14. doi:10.1128/mBio.01318-14.
Full Text & Related Files:
Abstract: ABSTRACT The catalytic site of the HIV integrase is contained within an RNase H-like fold, and numerous drugs have been developed that bind to this site and inhibit its activity. Herpes simplex virus (HSV) encodes two proteins with potential RNase H-like folds, the infected cell protein 8 (ICP8) DNA-binding protein, which is necessary for viral DNA replication and exhibits recombinase activity in vitro, and the viral terminase, which is essential for viral DNA cleavage and packaging. Therefore, we hypothesized that HIV integrase inhibitors might also inhibit HSV replication by targeting ICP8 and/or the terminase. To test this, we evaluated the effect of 118-D-24, a potent HIV integrase inhibitor, on HSV replication. We found that 118-D-24 inhibited HSV-1 replication in cell culture at submillimolar concentrations. To identify more potent inhibitors of HSV replication, we screened a panel of integrase inhibitors, and one compound with greater anti-HSV-1 activity, XZ45, was chosen for further analysis. XZ45 significantly inhibited HSV-1 and HSV-2 replication in different cell types, with 50% inhibitory concentrations that were approximately 1 µM, but exhibited low cytotoxicity, with a 50% cytotoxic concentration greater than 500 µM. XZ45 blocked HSV viral DNA replication and late gene expression. XZ45 also inhibited viral recombination in infected cells and ICP8 recombinase activity in vitro. Furthermore, XZ45 inhibited human cytomegalovirus replication and induction of Kaposi’s sarcoma herpesvirus from latent infection. Our results argue that inhibitors of enzymes with RNase H-like folds may represent a general antiviral strategy, which is useful not only against HIV but also against herpesviruses.
Published Version: doi:10.1128/mBio.01318-14
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search